SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies - Quaterly Results

29 May 2023 Evaluate
The revenue for the March 2023 quarter is pegged at Rs. 1485.30 millions, about 15.35% up against Rs. 1287.70 millions recorded during the year-ago period.The Net Profit of the company vaulted to 211.57% to Rs. 75.40  millions from Rs. 24.20 millions in the previous quarter.The company reported a good operating profit of 242.70 millions compared to 97.80 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1485.30 1287.70 15.35 5376.60 5767.10 -6.77 5376.60 5767.10 -6.77
Other Income 32.40 24.70 31.17 101.70 84.30 20.64 101.70 84.30 20.64
PBIDT 242.70 97.80 148.16 717.00 772.50 -7.18 717.00 772.50 -7.18
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 242.70 97.80 148.16 717.00 772.50 -7.18 717.00 772.50 -7.18
Depreciation 80.60 73.60 9.51 313.70 325.80 -3.71 313.70 325.80 -3.71
PBT 162.10 24.20 569.83 403.30 446.70 -9.72 403.30 446.70 -9.72
TAX 86.70 0.00 0.00 113.70 -43.20 -363.19 113.70 -43.20 -363.19
Deferred Tax 86.70 0.00 0.00 113.70 -43.20 -363.19 113.70 -43.20 -363.19
PAT 75.40 24.20 211.57 289.60 489.90 -40.89 289.60 489.90 -40.89
Equity 133.70 133.70 0.00 133.70 133.70 0.00 133.70 133.70 0.00
PBIDTM(%) 16.34 7.59 115.15 13.34 13.39 -0.44 13.34 13.39 -0.44

Venus Remedies Share Price

1042.35 3.25 (0.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×